Literature DB >> 12682122

Development of a real-time PCR assay for quantitative detection of Encephalitozoon intestinalis DNA.

Jean Menotti1, Bruno Cassinat, Claudine Sarfati, Olivier Liguory, Francis Derouin, Jean-Michel Molina.   

Abstract

A new real-time PCR assay for quantitation of Encephalitozoon intestinalis DNA was developed which used a TaqMan fluorescent probe for specific detection. Serial dilutions of E. intestinalis spore suspensions obtained from tissue culture were used as external standards. The detection limit of the technique was 20 spores per ml, with a good interassay reproducibility (coefficient of variation of 7.1% for the suspension containing 20 spores/ml, 5.0% for the suspension containing 75 spores/ml and below 3.5% for higher concentrations). Quantitative detection of E. intestinalis DNA was similar whether the serial dilutions of spores were made in distilled water or in a stool suspension, allowing the use of the assay for stool specimens. The assay was then applied to 14 clinical specimens from 8 immunocompromised patients with proven E. intestinalis infection. The quantitation of the parasitic burden was achieved in stools, blood, urine, tissue biopsies, and bronchopulmonary specimens. The highest parasitic burdens were noted in stools, urine, and bronchopulmonary specimens, reaching 10(5) to 10(6) spores/g or ml. Dissemination of the infection was also evidenced in some patients by demonstration of E. intestinalis DNA in blood and serum. We conclude that real-time PCR is a valuable tool for quantitation of E. intestinalis burden in clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682122      PMCID: PMC153894          DOI: 10.1128/JCM.41.4.1410-1413.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Genetic homology among thirteen Encephalitozoon intestinalis isolates obtained from human immunodeficiency virus-infected patients with intestinal microsporidiosis.

Authors:  O Liguory; S Fournier; C Sarfati; F Derouin; J M Molina
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Taxonomy of phylum microspora.

Authors:  V Sprague; J J Becnel; E I Hazard
Journal:  Crit Rev Microbiol       Date:  1992       Impact factor: 7.624

3.  Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial.

Authors:  J M Molina; C Chastang; J Goguel; J F Michiels; C Sarfati; I Desportes-Livage; J Horton; F Derouin; J Modaï
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

4.  Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique.

Authors:  T van Gool; F Snijders; P Reiss; J K Eeftinck Schattenkerk; M A van den Bergh Weerman; J F Bartelsman; J J Bruins; E U Canning; J Dankert
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

5.  Septata intestinalis frequently isolated from stool of AIDS patients with a new cultivation method.

Authors:  T van Gool; E U Canning; H Gilis; M A van den Bergh Weerman; J K Eeftinck Schattenkerk; J Dankert
Journal:  Parasitology       Date:  1994-09       Impact factor: 3.234

6.  Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group.

Authors:  R Weber; R T Bryan; R L Owen; C M Wilcox; L Gorelkin; G S Visvesvara
Journal:  N Engl J Med       Date:  1992-01-16       Impact factor: 91.245

7.  Septata intestinalis N. G., N. Sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients.

Authors:  A Cali; D P Kotler; J M Orenstein
Journal:  J Eukaryot Microbiol       Date:  1993 Jan-Feb       Impact factor: 3.346

8.  Systemic dissemination by a newly recognized intestinal microsporidia species in AIDS.

Authors:  J M Orenstein; D T Dieterich; D P Kotler
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

Review 9.  Human microsporidial infections.

Authors:  R Weber; R T Bryan; D A Schwartz; R L Owen
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

10.  Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy.

Authors:  J M Molina; E Oksenhendler; B Beauvais; C Sarfati; A Jaccard; F Derouin; J Modaï
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more
  17 in total

Review 1.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

2.  Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.

Authors:  Peter J Didier; Jennifer N Phillips; Dorothy J Kuebler; Mohamed Nasr; Paul J Brindley; Mary E Stovall; Lisa C Bowers; E S Didier
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Performance of Real-Time Polymerase Chain Reaction Assays for the Detection of 20 Gastrointestinal Parasites in Clinical Samples from Senegal.

Authors:  Doudou Sow; Philippe Parola; Khadime Sylla; Magatte Ndiaye; Pascal Delaunay; Philippe Halfon; Sabine Camiade; Thérèse Dieng; Roger C K Tine; Babacar Faye; Jean Louis Ndiaye; Yémou Dieng; Oumar Gaye; Didier Raoult; Fadi Bittar
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

Review 4.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Inhibitory activity of human immunodeficiency virus aspartyl protease inhibitors against Encephalitozoon intestinalis evaluated by cell culture-quantitative PCR assay.

Authors:  Jean Menotti; Maud Santillana-Hayat; Bruno Cassinat; Claudine Sarfati; Francis Derouin; Jean-Michel Molina
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Detection and identification of Enterocytozoon bieneusi and Encephalitozoon species in stool and urine specimens by PCR and differential hybridization.

Authors:  Daan W Notermans; Ron Peek; Menno D de Jong; Ellen M Wentink-Bonnema; René Boom; Tom van Gool
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

8.  Cytometric approach for detection of Encephalitozoon intestinalis, an emergent agent.

Authors:  Joana Barbosa; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Clin Vaccine Immunol       Date:  2009-05-13

9.  Molecular study of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon intestinalis among human immunodeficiency virus-infected patients from two geographical areas: Niamey, Niger, and Hanoi, Vietnam.

Authors:  Anne Espern; Florent Morio; Michel Miegeville; Hachimou Illa; Moustapha Abdoulaye; Vanina Meyssonnier; Eric Adehossi; Anne Lejeune; Phung Dac Cam; Bernard Besse; Françoise Gay-Andrieu
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

10.  Comparative Assessment of In-House Real-Time PCRs Targeting Enteric Disease-Associated Microsporidia in Human Stool Samples.

Authors:  Konstantin Tanida; Andreas Hahn; Kirsten Alexandra Eberhardt; Egbert Tannich; Olfert Landt; Simone Kann; Torsten Feldt; Fred Stephen Sarfo; Veronica Di Cristanziano; Hagen Frickmann; Ulrike Loderstädt
Journal:  Pathogens       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.